🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the effect of 24 weeks of treatme...
Status
Terminated
Location
University of Arizona
Start Date
2003-05
Trial ID
NCT00060801
Treatments Being Tested
The objective of the present study is to investigate the relative bioavaila...
Status
Completed
Location
Multiple Locations
Start Date
2001-10
Trial ID
NCT02265666
Treatments Being Tested
Safety, pharmacokinetics, pharmacodynamics \[CD11b/CD18 (Mac-1) expression\...
Status
Completed
Location
Multiple Locations
Start Date
2000-01
Trial ID
NCT02247375
Treatments Being Tested
To evaluate the effect of multiple doses of BIIL 284 BS on the pharmacokine...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT02273440
Treatments Being Tested
Safety, tolerability and pharmacokinetics following single doses...
Status
Completed
Location
Multiple Locations
Start Date
2001-10
Trial ID
NCT02265679
The aims of this phase I study are to define the metabolism, excretion and ...
Status
Completed
Location
Multiple Locations
Start Date
1999-10
Trial ID
NCT02266550
Treatments Being Tested
Study to investigate the effect of 14-day treatment with BIIL 284 BS on spu...
Status
Completed
Location
Multiple Locations
Start Date
1999-10
Trial ID
NCT02249338
Treatments Being Tested
To investigate the pharmacokinetics of a single dose of BIIL 284 BS in pati...
Status
Completed
Location
Multiple Locations
Start Date
2000-03
Trial ID
NCT02265627
Treatments Being Tested
Study to evaluate the anti-inflammatory effect of BIIL 284 BS compared with...
Status
Completed
Location
Multiple Locations
Start Date
1999-07
Trial ID
NCT02249312
Treatments Being Tested
The objective of the present study is to investigate the relative bioavaila...
Status
Completed
Location
Multiple Locations
Start Date
1999-11
Trial ID
NCT02265653
Treatments Being Tested